These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 32499572)
1. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth. Lechertier T; Reynolds LE; Kim H; Pedrosa AR; Gómez-Escudero J; Muñoz-Félix JM; Batista S; Dukinfield M; Demircioglu F; Wong PP; Matchett KP; Henderson NC; D'Amico G; Parsons M; Harwood C; Meier P; Hodivala-Dilke KM Nat Commun; 2020 Jun; 11(1):2810. PubMed ID: 32499572 [TBL] [Abstract][Full Text] [Related]
2. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival. Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of pericyte FAK-Y861 affects tumour cell apoptosis and tumour blood vessel regression. Lees DM; Reynolds LE; Pedrosa AR; Roy-Luzarraga M; Hodivala-Dilke KM Angiogenesis; 2021 Aug; 24(3):471-482. PubMed ID: 33730293 [TBL] [Abstract][Full Text] [Related]
4. Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK. Zhang J; Li W; Wang W; Chen Q; Xu Z; Deng M; Zhou L; He G Eur J Pharmacol; 2023 May; 947():175694. PubMed ID: 36967077 [TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits angiogenesis by blocking Gas6/Axl signaling pathway. Li X; Chen M; Lei X; Huang M; Ye W; Zhang R; Zhang D Int J Oncol; 2017 Aug; 51(2):677-685. PubMed ID: 28627676 [TBL] [Abstract][Full Text] [Related]
10. S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma. Xiao Y; Zhao H; Tian L; Nolley R; Diep AN; Ernst A; Fuh KC; Miao YR; von Eyben R; Leppert JT; Brooks JD; Peehl DM; Giaccia AJ; Rankin EB Cancer Res; 2019 Nov; 79(22):5758-5768. PubMed ID: 31585940 [TBL] [Abstract][Full Text] [Related]
11. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Franco M; Roswall P; Cortez E; Hanahan D; Pietras K Blood; 2011 Sep; 118(10):2906-17. PubMed ID: 21778339 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601 [TBL] [Abstract][Full Text] [Related]
13. Dual role of pericyte α6β1-integrin in tumour blood vessels. Reynolds LE; D'Amico G; Lechertier T; Papachristodoulou A; Muñoz-Félix JM; De Arcangelis A; Baker M; Serrels B; Hodivala-Dilke KM J Cell Sci; 2017 May; 130(9):1583-1595. PubMed ID: 28289267 [TBL] [Abstract][Full Text] [Related]
14. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Png KJ; Halberg N; Yoshida M; Tavazoie SF Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610 [TBL] [Abstract][Full Text] [Related]
15. AXL is an oncotarget in human colorectal cancer. Martinelli E; Martini G; Cardone C; Troiani T; Liguori G; Vitagliano D; Napolitano S; Morgillo F; Rinaldi B; Melillo RM; Liotti F; Nappi A; Bianco R; Berrino L; Ciuffreda LP; Ciardiello D; Iaffaioli V; Botti G; Ferraiolo F; Ciardiello F Oncotarget; 2015 Sep; 6(27):23281-96. PubMed ID: 25966280 [TBL] [Abstract][Full Text] [Related]
17. The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Nisancioglu MH; Betsholtz C; Genové G Cancer Res; 2010 Jun; 70(12):5109-15. PubMed ID: 20501841 [TBL] [Abstract][Full Text] [Related]
18. Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. Kaneda T; Sonoda Y; Ando K; Suzuki T; Sasaki Y; Oshio T; Tago M; Kasahara T Cancer Lett; 2008 Nov; 270(2):354-61. PubMed ID: 18606490 [TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase regulates smooth muscle cell recruitment to the developing vasculature. Cheng Z; Sundberg-Smith LJ; Mangiante LE; Sayers RL; Hakim ZS; Musunuri S; Maguire CT; Majesky MW; Zhou Z; Mack CP; Taylor JM Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2193-202. PubMed ID: 21757658 [TBL] [Abstract][Full Text] [Related]
20. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Zhu C; Wei Y; Wei X Mol Cancer; 2019 Nov; 18(1):153. PubMed ID: 31684958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]